Fundz

Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer

PUBLIC · KYMRApr 09, 2025

Position

Chief Business Officer

Company

Kymera Therapeutics

Noah Goodman
ngoodman@kymeratx.com
CambridgeBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Kymera Therapeutics has announced the appointment of Noah Goodman as Chief Business Officer. He brings extensive experience and will lead the business development strategy at Kymera.

Quick answer

Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer (April 9, 2025). Kymera Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Business Officer at Kymera Therapeutics?
Kymera Therapeutics named Noah Goodman Chief Business Officer, announced April 9, 2025.
What did Kymera Therapeutics announce on April 9, 2025?
Kymera Therapeutics has announced the appointment of Noah Goodman as Chief Business Officer. He brings extensive experience and will lead the business development strategy at Kymera.
What does Kymera Therapeutics do?
Kymera Therapeutics (Nasdaq: KYMR) is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential...
Where is Kymera Therapeutics based?
Kymera Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (April 16, 2025), Cantargia AB (April 1, 2025), Bristol Myers Squibb (March 20, 2025) and Avadel (May 13, 2025) also announced leadership changes within 45 days of Kymera Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kymera Therapeutics, and when

A new leader at Kymera Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kymera Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kymera Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kymera Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kymera Therapeutics

Location

Cambridge, Massachusetts, United States

About

Kymera Therapeutics (Nasdaq: KYMR) is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kymera Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jaclyn
Senior decision-maker at this company
••••••••@••••••••

See Jaclyn's verified email →

Nello
Senior decision-maker at this company
••••••••@••••••••

See Nello's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kymera Therapeutics's next move

Learn about Strategic plan

Kymera Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.